🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicenter, prospective, observational, non-interventional study inve...
Status
Completed
Location
Klinikum Schön Klinik Bad Aibling SE & Co. KG
Start Date
2019-09-19
Trial ID
NCT04062097
To study thrombin generation parameters in critically ill patients with and...
Status
Unknown
Location
Queen Mary Hospital
Start Date
2024-04-06
Trial ID
NCT06094387
Treatments Being Tested
Dabigatran represent a new class of promising anticoagulation agents. As an...
Status
Completed
Location
Johann Wolfgang Goethe University Hospital
Start Date
2010-04
Trial ID
NCT01112202
The proposed PIVOTAL study will examine a panel of platelet/coagulation act...
Status
Completed
Location
Bellevue Hospital Center, South Manhattan Healthcare Network
Start Date
2013-06
Trial ID
NCT01897103
This study is open to adults aged between 18 and 80 years of age with a bod...
Status
Recruiting
Location
Inland Empire Clinical Trials, LLC
Start Date
2025-07-17
Trial ID
NCT07023354
Treatments Being Tested
To assess the safety, pharmacokinetics and efficacy of a plasma-derived AT-...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT00319228
Treatments Being Tested
The objectives of this registry are to assess the use of the thrombin-speci...
Status
Completed
Location
Nycomed
Start Date
2005-03
Trial ID
NCT00290849
Treatments Being Tested
The purpose of this study is to determine whether it is safe to stop antico...
Status
Terminated
Location
Jeffrey Goodman, MD
Start Date
2013-01
Trial ID
NCT01650298
Treatments Being Tested
The purpose of this post-market observational registry is to collect additi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-12
Trial ID
NCT03772912
Treatments Being Tested
An Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study to...
Status
Terminated
Location
Shands University of Florida
Start Date
2019-05-16
Trial ID
NCT03809481
Treatments Being Tested